Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ghesquiéres, Hervé
498  Ergebnisse:
Personensuche X
?
1

Impact of Bridging Therapy (BT) on Lisocabtagene Maraleucel..:

Dahiya, Saurabh ; Hirayama, Alexandre V. ; Schuster, Stephen J....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S212 , 2024
Link: https://doi.org/10.1016/..
 
?
2

ABCL-193 Impact of Bridging Therapy (BT) on Lisocabtagene M..:

Dahiya, Saurabh ; Hirayama, Alexandre V. ; Schuster, Stephen J....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S462-S463 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Early follow-up of outpatients with oral anticancer therapy..:

Lattard, Claire ; Herledan, Chloé ; Reverdy, Thibaut...
The Oncologist.  , 2024
Link: https://doi.org/10.1093/..
 
?
4

A quick access to information on influenza burden and preve..:

Khanafer, Nagham ; Oudot, Sylvain ; Maligeay, Margot...
Vaccine.  42 (2024)  21 - p. 126160 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Evaluation of participation and recruitment bias in a prosp..:

Lan, Caroline Le ; Belot, Aurélien ; Golfier, Camille...
Hematological Oncology.  42 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
6

Brentuximab Vedotin (BV) in Combination With Lenalidomide (..:

Yasenchak, Christopher ; Kim, Jeong-A ; Hahn, Uwe...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S156 , 2024
Link: https://doi.org/10.1016/..
 
?
7

A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ci..:

Ghione, Paola ; Palomba, M. Lia ; Ray, Markqayne D....
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
8

Brentuximab Vedotin (BV) in Combination With Lenalidomide (..:

Yasenchak, Christopher ; Kim, Jeong-A ; Hahn, Uwe...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S220 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Extended Follow-Up Beyond 2 .5 Years Demonstrates Long-Term..:

Karimi, Yasmin H. ; Thieblemont, Catherine ; Ghesquieres, Herve...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S212 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Author Correction: Lisocabtagene maraleucel in follicular l..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine.  30 (2024)  8 - p. 2374-2374 , 2024
Link: https://doi.org/10.1038/..
 
?
11

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine.  30 (2024)  8 - p. 2199-2207 , 2024
Link: https://doi.org/10.1038/..
 
?
12

ABCL-191 Extended Follow-Up Beyond 2.5 Years Demonstrates L..:

Karimi, Yasmin H. ; Thieblemont, Catherine ; Ghesquieres, Herve...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S461-S462 , 2024
Link: https://doi.org/10.1016/..
 
?
13

IELSG38: phase II trial of front-line chlorambucil plus sub..:

Stathis, Anastasios ; Pirosa, Maria Cristina ; Orsucci, Lorella...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
14

Challenges for quality and utilization of real-world data f..:

Ghesquières, Hervé ; Cherblanc, Fanny ; Belot, Aurélien...
Blood Advances.  8 (2024)  2 - p. 296-308 , 2024
Link: https://doi.org/10.1182/..
 
?
15

Autologous stem cell transplantation in T-cell/histiocyte-r..:

Renders, Simon ; Ngoya, Maud ; Finel, Herve...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
1-15